1 hasil untuk "Ruby Arai"

Use of Upadacitinib in elderly patients with IBD: a case series

Ruby Arai; Kazuyo Okayama; Takanori Nishiguchi dkk.

Journal of Pharmaceutical Health Care and Sciences, Vol. 12 No. 1 · 2026 · Inggris · DOAJ Scopus

Abstract Background Upadacitinib (UPA) is a selective Janus kinase (JAK) 1 inhibitor that may rapidly induce and maintain a remission of inflammatory bowel disease (IBD) through potent suppression of cytokine signaling. While a pan-JAK inhibitor has been shown to increase the risk of thromboembolic…